Leung K, Cai J, Liu Y, Chan K, Shao J, Yang H
Leukemia. 2023; 38(2):250-257.
PMID: 38001171
PMC: 10844073.
DOI: 10.1038/s41375-023-02089-3.
Schneider P, Crump N, Arentsen-Peters S, Smith A, Hagelaar R, Adriaanse F
Exp Hematol Oncol. 2023; 12(1):81.
PMID: 37740239
PMC: 10517487.
DOI: 10.1186/s40164-023-00445-8.
Santos M, Santos A, Santos H, Santos L, Nascimento R, Torres A
Einstein (Sao Paulo). 2023; 21:eAO0117.
PMID: 36629681
PMC: 9785573.
DOI: 10.31744/einstein_journal/2023AO0117.
Pacelli P, Raspadori D, Bestoso E, Gozzetti A, Bocchia M
Front Oncol. 2022; 12:1057713.
PMID: 36518304
PMC: 9742464.
DOI: 10.3389/fonc.2022.1057713.
Varotto E, Munaretto E, Stefanachi F, Della Torre F, Buldini B
Front Pediatr. 2022; 10:911093.
PMID: 36245718
PMC: 9554480.
DOI: 10.3389/fped.2022.911093.
Evaluation of fixed-panel, multicolour ClearLLab 10C at an academic flow cytometry laboratory in Johannesburg, South Africa.
Glencross D, Swart L, Pretorius M, Lawrie D
Afr J Lab Med. 2022; 11(1):1458.
PMID: 35937760
PMC: 9350555.
DOI: 10.4102/ajlm.v11i1.1458.
Flow Cytometry Immunophenotyping for Diagnostic Orientation and Classification of Pediatric Cancer Based on the EuroFlow Solid Tumor Orientation Tube (STOT).
Ferreira-Facio C, Botafogo V, Ferrao P, Canellas M, Milito C, Romano S
Cancers (Basel). 2021; 13(19).
PMID: 34638431
PMC: 8508207.
DOI: 10.3390/cancers13194945.
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts.
Quintarelli C, Guercio M, Manni S, Boffa I, Sinibaldi M, Di Cecca S
J Immunother Cancer. 2021; 9(6).
PMID: 34135100
PMC: 8211055.
DOI: 10.1136/jitc-2020-001514.
Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.
Vega-Garcia N, Perez-Jaume S, Esperanza-Cebollada E, Vicente-Garces C, Torrebadell M, Jimenez-Velasco A
Front Pediatr. 2021; 8:614521.
PMID: 33614543
PMC: 7892614.
DOI: 10.3389/fped.2020.614521.
In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes.
Opie J, Antel K, Koller A, Novitzky N
Ann Hematol. 2020; 99(3):571-578.
PMID: 31955214
PMC: 7258179.
DOI: 10.1007/s00277-020-03908-8.
Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact.
Devin J, Kassambara A, Bruyer A, Moreaux J, Bret C
J Clin Med. 2019; 8(7).
PMID: 31336593
PMC: 6678649.
DOI: 10.3390/jcm8071074.
An ontology for representing hematologic malignancies: the cancer cell ontology.
Serra L, Duncan W, Diehl A
BMC Bioinformatics. 2019; 20(Suppl 5):181.
PMID: 31272372
PMC: 6509834.
DOI: 10.1186/s12859-019-2722-8.
Injection of Adipose-Derived Stromal Cells in the Knee of Patients with Severe Osteoarthritis has a Systemic Effect and Promotes an Anti-Inflammatory Phenotype of Circulating Immune Cells.
Pers Y, Quentin J, Feirreira R, Espinoza F, Abdellaoui N, Erkilic N
Theranostics. 2018; 8(20):5519-5528.
PMID: 30555561
PMC: 6276295.
DOI: 10.7150/thno.27674.
New Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell Lymphoid Malignancies.
Dogliotti I, Drandi D, Genuardi E, Ferrero S
J Clin Med. 2018; 7(9).
PMID: 30231510
PMC: 6162632.
DOI: 10.3390/jcm7090288.
Methods and role of minimal residual disease after stem cell transplantation.
Ladetto M, Bottcher S, Kroger N, Pulsipher M, Bader P
Bone Marrow Transplant. 2018; 54(5):681-690.
PMID: 30116018
DOI: 10.1038/s41409-018-0307-1.
Deep sustained response to daratumumab monotherapy associated with T-cell expansion in triple refractory myeloma.
Usmani S, Khan I, Chiu C, Foureau D, Druhan L, Rigby K
Exp Hematol Oncol. 2018; 7:3.
PMID: 29445583
PMC: 5804097.
DOI: 10.1186/s40164-018-0096-7.
Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia - role of blinatumomab.
Queudeville M, Handgretinger R, Ebinger M
Onco Targets Ther. 2017; 10:3567-3578.
PMID: 28790849
PMC: 5530848.
DOI: 10.2147/OTT.S103470.
Role of new Immunophenotypic Markers on Prognostic and Overall Survival of Acute Myeloid Leukemia: a Systematic Review and Meta-Analysis.
Costa A, Menezes D, Pinheiro L, Sandes A, Nunes M, Lyra Junior D
Sci Rep. 2017; 7(1):4138.
PMID: 28646224
PMC: 5482890.
DOI: 10.1038/s41598-017-00816-2.
Expression of the Class II and III Beta-Tubulin in Neoplastic and Non-Neoplastic Lymphoid Tissues.
Binti Yusof N, Ameli F, Florence C, Mustangin M, Rahman F, Masir N
Asian Pac J Cancer Prev. 2017; 18(4):1045-1050.
PMID: 28547939
PMC: 5494214.
DOI: 10.22034/APJCP.2017.18.4.1045.
A QA Program for MRD Testing Demonstrates That Systematic Education Can Reduce Discordance Among Experienced Interpreters.
Keeney M, Wood B, Hedley B, DiGiuseppe J, Stetler-Stevenson M, Paietta E
Cytometry B Clin Cytom. 2017; 94(2):239-249.
PMID: 28475275
PMC: 8064036.
DOI: 10.1002/cyto.b.21528.